Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IQB-782 shows a potent mucolytic-expectorant activity. IQB-782 is a cysteine derivative. IQB-782 has inhibition for thrombin activatable fibrinolysis inhibitor (TAFI), with an Ki(app) of 0.14 μM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | IQB-782 shows a potent mucolytic-expectorant activity. IQB-782 is a cysteine derivative. IQB-782 has inhibition for thrombin activatable fibrinolysis inhibitor (TAFI), with an Ki(app) of 0.14 μM. |
Targets&IC50 | TAFI:(Kiapp)0.14 μM |
In vitro | IQB-782 inhibits TAFI related carboxypeptidases with IC50s of 12 μM and 49 μM for CPB and CPN, respectively. |
Molecular Weight | 163.2 |
Formula | C4H9N3O2S |
CAS No. | 40454-21-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IQB-782 40454-21-5 Others IQB 782 IQB782 inhibitor inhibit